Dr. Moody is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
450 Brookline Ave
Dana-Farber Cancer Institute
Boston, MA 02215Phone+1 617-632-3000
Education & Training
- Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2007 - 2011
- Brigham and Women's HospitalResidency, Internal Medicine, 2005 - 2007
- Perelman School of Medicine at the University of PennsylvaniaClass of 2005
Certifications & Licensure
- MA State Medical License 2007 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 15 citationsCellular dormancy in minimal residual disease following targeted therapy.Jason R. Ruth, Dhruv K. Pant, Tien-chi Pan, Hans E. Seidel, Sanjeethan C. Baksh
Breast Cancer Research. 2021-06-04 - 69 citationsPhase 1 study of single-agent WNT974, a first-in-class Porcupine inhibitor, in patients with advanced solid tumoursJordi Rodon, Guillem Argiles, Roisin M. Connolly, Ulka N. Vaishampayan, Maja J.A. de Jonge
British Journal of Cancer. 2021-05-03 - 81 citationsCombinations with Allosteric SHP2 Inhibitor TNO155 to Block Receptor Tyrosine Kinase Signaling.Chen Liu, Hengyu Lu, Hongyun Wang, Alice Loo, Xiamei Zhang
Clinical Cancer Research. 2021-01-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: